IL97324A0 - Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus - Google Patents

Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus

Info

Publication number
IL97324A0
IL97324A0 IL97324A IL9732491A IL97324A0 IL 97324 A0 IL97324 A0 IL 97324A0 IL 97324 A IL97324 A IL 97324A IL 9732491 A IL9732491 A IL 9732491A IL 97324 A0 IL97324 A0 IL 97324A0
Authority
IL
Israel
Prior art keywords
arthropoda
infection
expression
growth factor
nerve growth
Prior art date
Application number
IL97324A
Other languages
English (en)
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of IL97324A0 publication Critical patent/IL97324A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL97324A 1990-02-27 1991-02-21 Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus IL97324A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT41538A IT1239271B (it) 1990-02-27 1990-02-27 Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante

Publications (1)

Publication Number Publication Date
IL97324A0 true IL97324A0 (en) 1992-05-25

Family

ID=11250839

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97324A IL97324A0 (en) 1990-02-27 1991-02-21 Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus

Country Status (6)

Country Link
EP (1) EP0444638A3 (xx)
JP (1) JPH05103666A (xx)
KR (1) KR910021478A (xx)
HU (1) HUT56881A (xx)
IL (1) IL97324A0 (xx)
IT (1) IT1239271B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE206056T1 (de) * 1992-06-08 2001-10-15 Takeda Chemical Industries Ltd Therapeutisches agens für neutropenie
WO1994004184A2 (en) * 1992-08-12 1994-03-03 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US5618544A (en) * 1992-08-12 1997-04-08 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US6541447B1 (en) 1999-09-01 2003-04-01 B & M Healthcare Technologies, Inc. Wound healing composition and method for use thereof
FR2825273B1 (fr) * 2001-05-29 2006-11-24 Oreal Composition pour le traitement des signes cutanes du vieillissement
IT1394690B1 (it) 2008-10-23 2012-07-13 Carli De Metodo di trattamento dermocosmetico della cute mediante applicazione di composizioni contenenti ngf.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US4745051A (en) * 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Also Published As

Publication number Publication date
HU910643D0 (en) 1991-09-30
EP0444638A2 (en) 1991-09-04
IT9041538A0 (it) 1990-02-27
IT1239271B (it) 1993-10-01
IT9041538A1 (it) 1991-08-27
JPH05103666A (ja) 1993-04-27
EP0444638A3 (en) 1992-01-08
KR910021478A (ko) 1991-12-20
HUT56881A (en) 1991-10-28

Similar Documents

Publication Publication Date Title
AU4197389A (en) In vivo infection of live insects with a recombinant baculovirus
AU4133789A (en) Biological implant with textured surface
AU1011292A (en) Composite orthopedic implants with asymmetric ply reinforcement
AU5745290A (en) Improvements in or relating to medical ventilators
EP0441639A3 (en) Instrument for the application of controlled mechanical loads to tissues in sterile culture
AU583175B2 (en) Biological implant with textured surface
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
AU2898989A (en) Human platelet-derived growth factor receptor
ZA919259B (en) Active fragments of fibroblast growth factor
AU581574B2 (en) Fabric treatment to improve dyeability thereof
EP0462075A3 (en) Use of uridine in the pharmacological treatment of the peripheral complications of diabetes
EP0444638A3 (en) Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus
HU910129D0 (en) Absorbent tissue structure and process for its production
PT86153A (de) Optisch aktive gyrasehemmer ihre herstellung und verwendung als antibiotika
AU7291891A (en) Process for the isolation and expression of the human ciliary neuronotrophic factor by recombinant dna technology
EP0248656A3 (en) Composition for cell cultivation and use thereof
AU7953487A (en) Dermal treatment of worm diseases in cats with praziquantel
AU7082487A (en) Recombinant human b-cell growth factor
GB9216506D0 (en) Improvements in or relating to the treatment of sickle cell disease
AU589816B2 (en) Porous glass fiber mats for attachment of cells and biologically active substances
EP0426458A3 (en) Human monocyte growth factor
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors
AU6480590A (en) Improvements in and relating to supported lactic acid bacteria cultures
AU8189787A (en) Cotton harvester and tandem row unit therefor
NO874552D0 (no) Rekombinant human endotelial cellevekstfaktor.